logo
Select company
Select metric
$ 220.34MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
5
Sector
5
Industry
8
History
72
$ 6.49Close
$ 2 - $ 6.78 52-Week Range
Ticker Information

Ticker

RLAY

Company Name

RELAY THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RELAY THERAPEUTICS INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RLAY - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 220.34M
3/31/2025$ 221.23M
12/31/2024$ 270.15M
9/30/2024$ 291.27M
6/30/2024$ 81.84M
3/31/2024$ 82.38M
12/31/2023$ 34.75M
9/30/2023$ 14M
6/30/2023$ 290.41M
3/31/2023$ 290.32M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RELAY THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Equity stands at $ 429.02M.
  • Over the past 5 years, RELAY THERAPEUTICS INC's average CF - Equity has been $ 274.61M.
  • The median CF - Equity for RELAY THERAPEUTICS INC during this period was $ 290.32M
  • RELAY THERAPEUTICS INC reached its highest CF - Equity over the past 5 years at $ 672.76M.
  • The lowest CF - Equity recorded by RELAY THERAPEUTICS INC in the same timeframe $ 4.13M

RELAY THERAPEUTICS INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
TSHA : TAYSHA GENE THERAPIES INC $ 222.61MDNTH : DIANTHUS THERAPEUTICS INC $ 40.7MTNXP : TONIX PHARMACEUTICALS HOLDING CORP $ 199.65MPRME : PRIME MEDICINE INC $ 38.71MPGEN : PRECIGEN INC $ 31.4MPRTA : PROTHENA CORP PUBLIC LTD CO $ 152KABSI : ABSCI CORP $ 47.05MFATE : FATE THERAPEUTICS INC $ 0TVRD : TVARDI THERAPEUTICS INC $ 424KPRAX : PRAXIS PRECISION MEDICINES INC $ 199.48M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

RLAY - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 4.13M

Minimum

Sep 30, 2021

$ 672.76M

Maximum

Sep 30, 2022

$ 274.61M

Average

$ 290.32M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 124.49K with a standard deviation of $ 17.66M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 124.49K
median$ 0
std$ 17.66M